Drug Shortage Report for SOFRACORT
Report ID | 202983 |
Drug Identification Number | 02224623 |
Brand name | SOFRACORT |
Common or Proper name | Framycetin sulphate, Dexamethasone and Gramicidin Ophthalmic/Otic Solution |
Company Name | SANOFI-AVENTIS CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | GRAMICIDIN DEXAMETHASONE FRAMYCETIN SULFATE |
Strength(s) | 0.05MG 0.5MG 5MG |
Dosage form(s) | DROPS |
Route of administration | OTIC OPHTHALMIC OTIC OPHTHALMIC |
Packaging size | 8 mL bottle |
ATC code | S03CA |
ATC description | CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2023-08-28 |
Actual start date | 2023-08-28 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2023-12-01 |
Company comments | Requirements related to complying with good manufacturing practices. |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2023-12-01 | French | Compare |
v6 | 2023-12-01 | English | Compare |
v5 | 2023-10-02 | French | Compare |
v4 | 2023-10-02 | English | Compare |
v3 | 2023-08-29 | English | Compare |
v2 | 2023-08-25 | French | Compare |
v1 | 2023-08-25 | English | Compare |
Showing 1 to 7 of 7